Skip to main content
UniHealth

Doctor search

Leticia Rubalcava, PA

Physician Assistant · Stanford

NPI 1790238046

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1
Since medical school
10 years
Graduated 2016

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Leticia Rubalcava’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence G53641 · Current

Licensed to practise in California · since 1984 · expires 2028-05-31 · University of Kansas School of Medicine.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$28,975

Medicare paid this office $28,975 for 104 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)88$20,711$100
New patient visit (60+ min)32$5,322$166
Long return visit (40+ min)14$1,833$131

Who their Medicare patients are

104 Original Medicare patients in 2024. Average age 66 · Under 65 27% · Women 69% · Also on Medicaid 27% · Health risk score 1.41. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.

Conditions among them: High blood pressure 74% · Diabetes 36% · Depression 33% · Chronic kidney disease 22% · Cancer 20% · Coronary heart disease 16% · Heart failure 15% · Atrial fibrillation 13%.

The office billed $211,740, Medicare allowed $37,928 and paid $28,975; for 269 services of 6 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024104269661.41$211,740$28,975
20236998671.42$54,645$8,331
2022108329711.58$42,732$16,443
2021120322691.32$44,342$17,026
202079166661.28$25,610$8,847

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
New patient visit (60+ min)25$3,549$142
Return visit (30+ min)12$998$77
Short return visit (20+ min)16$807$40

2022: 7 services

Original Medicare services billed in 2022
Return visit (30+ min)54$4,840$60
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit25$3,026$121
Short return visit (20+ min)45$2,540$40
Telephone medical discussion with physician, 11-20 minutes41$1,721$31
Telephone medical discussion with physician, 21-30 minutes19$1,412$61
Annual depression screening, 5 to 15 minutes15$125$8
Annual alcohol misuse screening, 5 to 15 minutes14$117$8

2021: 6 services

Original Medicare services billed in 2021
Return visit (30+ min)62$5,627$64
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit24$2,964$124
Short return visit (20+ min)45$2,732$44
Telephone medical discussion with physician, 21-30 minutes35$1,912$44
Telephone medical discussion with physician, 11-20 minutes36$1,630$40
Short return visit19$495$24

2020: 3 services

Original Medicare services billed in 2020
Return visit (30+ min)60$4,664$48
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit12$1,310$109
Telephone medical discussion with physician, 21-30 minutes19$1,244$52

Medicaid work

$252 in 2024

Medicaid paid $252 for 14 billed services this clinician did in 2024, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Return visit (30+ min)14$252
Medicaid work by year
202414114$252
202112112$815
See the largest Medicaid services in earlier years

2021

Largest Medicaid services in 2021
Return visit (30+ min)12$815

Drugs they prescribed that Part D paid

$165,076

Pharmacies billed $165,076 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 430) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.

253 generic and 164 brand-name prescriptions · $165,076 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ozempic110$99,442$904
Mounjaro32$32,132$1,004
Wegovy16$25,880$1,617
Naltrexone27$581$22
Topiramate54$575$11
See all 9 drugs
Every Part D drug this clinician prescribed
Ozempic110$99,442$904
Mounjaro32$32,132$1,004
Wegovy16$25,880$1,617
Naltrexone27$581$22
Topiramate54$575$11
Metformin69$504$7
Bupropion Hcl Sr26$343$13
Ondansetron Odt13$291$22
Atorvastatin11$35$3

Year by year

Part D prescribing by year
2024430990% (0)38%$165,076
20239521650% (0)None$115,454
20222,058223NoneNone$177,923
20211,8122171% (11)11%$149,580
20205911132% (12)10%$39,326
201990150% (0)None$19,985
201845None0% (0)None$1,227

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 21 drugs

Part D drugs prescribed in 2023
Ozempic51$62,257$1,221
Atorvastatin66$1,208$18
Metformin108$1,004$9
Omeprazole37$682$18
Levothyroxine58$580$10
Losartan37$512$14
Topiramate38$421$11
Gabapentin22$398$18
Famotidine20$393$20
Gemfibrozil18$365$20
Losartan-Hydrochlorothiazide12$329$27
Escitalopram23$245$11
Amlodipine Besylate41$243$6
Lisinopril18$212$12
Fluticasone Propionate14$207$15
Metoprolol11$191$17
Sertraline21$188$9
Trazodone14$174$12
Pravastatin19$172$9
Pantoprazole17$162$10
Hydrochlorothiazide33$146$4

2022: 46 drugs

Part D drugs prescribed in 2022
Ozempic17$29,810$1,754
Januvia21$16,385$780
Dexilant11$3,669$334
Fenofibrate14$1,617$116
Atorvastatin133$1,559$12
Levothyroxine86$1,029$12
Omeprazole80$1,017$13
Rosuvastatin14$987$70
Metformin150$969$6
Albuterol Sulfate Hfa14$951$68
Losartan99$769$8
Bethanechol Chloride12$763$64
Bupropion Xl13$726$56
Amlodipine Besylate110$661$6
Clotrimazole17$648$38
Duloxetine25$502$20
Metoprolol24$436$18
Famotidine40$431$11
Diclofenac18$395$22
Bupropion Hcl Sr12$356$30
Benazepril23$346$15
Gabapentin39$341$9
Tamsulosin22$334$15
Pravastatin37$334$9
Fluticasone Propionate26$324$12
Lisinopril46$315$7
Sertraline41$309$8
Escitalopram29$307$11
Losartan-Hydrochlorothiazide15$305$20
Trazodone51$291$6
Hydrochlorothiazide75$267$4
Ketoconazole18$267$15
Alendronate38$214$6
Gemfibrozil23$202$9
Pantoprazole20$187$9
Topiramate22$179$8
Hydroxyzine23$173$8
Spironolactone21$161$8
Furosemide24$151$6
Ibuprofen29$146$5
Naproxen14$139$10
Latanoprost12$103$9
Triamcinolone Acetonide21$90$4
Meclizine16$83$5
Simvastatin13$72$6
Metoprolol11$53$5

2021: 46 drugs

Part D drugs prescribed in 2021
Victoza 3-Pak36$52,329$1,454
Linzess13$6,430$495
Tacrolimus11$1,876$171
Levothyroxine71$1,274$18
Fenofibrate24$1,234$51
Buspirone23$1,011$44
Losartan79$962$12
Topiramate18$947$53
Atorvastatin83$915$11
Bupropion Xl20$840$42
Diclofenac24$805$34
Gabapentin29$803$28
Omeprazole81$733$9
Ondansetron25$704$28
Losartan-Hydrochlorothiazide14$635$45
Metoprolol29$610$21
Metformin114$600$5
Amlodipine Besylate70$571$8
Albuterol Sulfate Hfa13$555$43
Naltrexone15$546$36
Clotrimazole13$539$41
Rosuvastatin14$525$38
Famotidine32$463$14
Benazepril-Hydrochlorothiazide13$378$29
Pravastatin18$373$21
Dicyclomine15$358$24
Hydrochlorothiazide62$329$5
Escitalopram31$316$10
Fluticasone Propionate18$287$16
Pantoprazole26$280$11
Lisinopril35$244$7
Naproxen24$244$10
Trazodone35$243$7
Sertraline23$199$9
Bupropion Hcl Sr16$186$12
Triamcinolone Acetonide27$171$6
Meclizine18$168$9
Simvastatin26$167$6
Hydroxyzine26$158$6
Alendronate35$148$4
Metoprolol19$134$7
Benazepril13$124$10
Ibuprofen13$81$6
Metformin Hcl Er12$76$6
Meloxicam18$56$3
Citalopram Hbr12$43$4

2020: 17 drugs

Part D drugs prescribed in 2020
Victoza 3-Pak19$20,234$1,065
Naltrexone18$982$55
Topiramate23$742$32
Levothyroxine13$213$16
Amlodipine Besylate18$206$11
Fluticasone Propionate14$200$14
Losartan28$198$7
Atorvastatin13$194$15
Metformin39$190$5
Alendronate16$169$11
Gabapentin12$131$11
Omeprazole15$124$8
Hydrochlorothiazide22$108$5
Hydroxyzine13$100$8
Lisinopril11$72$7
Metformin Hcl Er21$71$3
Trazodone11$34$3

2019: 4 drugs

Part D drugs prescribed in 2019
Victoza 3-Pak16$14,355$897
Topiramate14$1,192$85
Naltrexone20$1,082$54
Metformin Hcl Er13$119$9

2018: 2 drugs

Part D drugs prescribed in 2018
Topiramate14$600$43
Metformin Hcl Er16$55$3

Money from drug and device companies

$22 in 2025

Industry payments by year
202511None$22
202359None$180
20221540None$815
20211224None$484

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbvieUbrelvy$22
1 payment
  • Meals for Ubrelvy · 2025-10-02 · $22
See the published payment
Every published payment
AbbvieMeals · 2025-10-02Ubrelvy$22
See earlier years (2023, 2022, 2021)

2023: $180

Payments by company in 2023
Regeneron Healthcare SolutionsDupixent$63
3 payments
  • Meals for Dupixent · 2023-06-10 · $26
  • Meals for Dupixent · 2023-04-22 · $16
  • Meals for Dupixent · 2023-03-10 · $21
Lilly USAMounjaro$43
2 payments
  • Meals for Mounjaro · 2023-05-19 · $22
  • Meals for Emgality · 2023-04-14 · $21
Novo NordiskRybelsus$35
2 payments
  • Meals for Rybelsus · 2023-03-24 · $21
  • Meals for Ozempic · 2023-02-25 · $15
GenzymeDupixent$20
1 payment
  • Meals for Dupixent · 2023-01-20 · $20
AstraZeneca Pharmaceuticals LPFasenra$19
1 payment
  • Meals for Fasenra · 2023-05-06 · $19

2022: $815

Payments by company in 2022
Novo NordiskSaxenda$181
10 payments
  • Meals for Saxenda · 2022-09-20 · $24
  • Meals · 2022-09-03 · $16
  • Meals · 2022-08-16 · $18
  • Meals · 2022-07-29 · $15
  • Meals for Saxenda · 2022-06-23 · $18
  • Meals · 2022-06-17 · $13
  • Meals for Saxenda · 2022-06-03 · $20
  • Meals for Saxenda · 2022-04-29 · $22
  • Meals · 2022-04-12 · $14
  • Meals for Wegovy · 2022-02-26 · $22
Regeneron Healthcare SolutionsDupixent$104
4 payments
  • Meals for Dupixent · 2022-12-02 · $20
  • Meals for Dupixent · 2022-11-04 · $22
  • Meals for Dupixent · 2022-02-19 · $30
  • Meals for Dupixent · 2022-01-21 · $31
Boehringer Ingelheim PharmaceuticalsJardiance$103
4 payments
  • Meals for Tradjenta · 2022-08-04 · $28
  • Meals for Jardiance · 2022-05-19 · $24
  • Meals for Jardiance · 2022-02-24 · $24
  • Meals for Jardiance · 2022-01-07 · $28
Bayer HealthCare PharmaceuticalsKerendia$95
4 payments
  • Meals for Kerendia · 2022-10-05 · $18
  • Meals for Kerendia · 2022-08-29 · $27
  • Meals for Kerendia · 2022-05-10 · $25
  • Meals for Kerendia · 2022-04-12 · $25
Lilly USAMounjaro$92
4 payments
  • Meals for Emgality · 2022-09-09 · $19
  • Meals for Mounjaro · 2022-08-23 · $22
  • Meals for Mounjaro · 2022-07-12 · $28
  • Meals for Trulicity · 2022-04-26 · $23
Biohaven Pharmaceutical Holding CompanyNurtec Odt$43
3 payments
  • Meals for Nurtec Odt · 2022-10-05 · $15
  • Meals for Nurtec Odt · 2022-07-20 · $16
  • Meals for Nurtec Odt · 2022-03-09 · $12
GenzymeDupixent$36
2 payments
  • Meals for Dupixent · 2022-08-05 · $18
  • Meals for Dupixent · 2022-06-17 · $18
Abbott LaboratoriesInfinity$34
2 payments
  • Meals for Freestyle Libre 2 · 2022-08-02 · $15
  • Meals for Infinity · 2022-07-12 · $19
Phadia USImmunocap$21
1 payment
  • Meals for Immunocap · 2022-03-15 · $21
Xeris PharmaceuticalsGvoke Pfs$21
1 payment
  • Meals for Gvoke Pfs · 2022-02-01 · $21
Merck Sharp & DohmeGardasil 9$20
1 payment
  • Meals for Gardasil 9 · 2022-03-08 · $20
Sanofi PasteurVaxelis$17
1 payment
  • Meals for Vaxelis · 2022-05-03 · $17
OrganonNexplanon$17
1 payment
  • Meals for Nexplanon · 2022-01-24 · $17
Gilead SciencesNone$16
1 payment
  • Meals · 2022-07-27 · $16
Zealand Pharma USZegalogue$13
1 payment
  • Meals for Zegalogue · 2022-03-04 · $13

2021: $484

Payments by company in 2021
Novo NordiskSaxenda$145
7 payments
  • Meals for Wegovy · 2021-12-14 · $19
  • Meals for Saxenda · 2021-06-03 · $19
  • Meals for Saxenda · 2021-03-26 · $17
  • Meals · 2021-03-20 · $20
  • Meals for Saxenda · 2021-02-19 · $25
  • Meals · 2021-02-12 · $25
  • Meals · 2021-02-11 · $20
Boehringer Ingelheim PharmaceuticalsJardiance$124
5 payments
  • Meals for Jardiance · 2021-11-19 · $23
  • Meals for Jardiance · 2021-09-17 · $21
  • Meals for Jardiance · 2021-08-20 · $25
  • Meals for Jardiance · 2021-05-14 · $29
  • Meals for Jardiance · 2021-01-22 · $25
Lilly USABaqsimi$38
2 payments
  • Meals for Baqsimi · 2021-04-30 · $13
  • Meals for Baqsimi · 2021-03-03 · $25
AmgenEvenity$34
2 payments
  • Meals for Evenity · 2021-12-02 · $15
  • Meals for Evenity · 2021-09-24 · $18
OrganonNexplanon$24
1 payment
  • Meals for Nexplanon · 2021-11-08 · $24
Regeneron Healthcare SolutionsDupixent$23
1 payment
  • Meals for Dupixent · 2021-10-29 · $23
Merck Sharp & DohmeBelsomra$21
1 payment
  • Meals for Belsomra · 2021-10-18 · $21
Dynavax TechnologiesHeplisav-B$19
1 payment
  • Meals for Heplisav-B · 2021-10-12 · $19
Bayer HealthCare PharmaceuticalsKerendia$17
1 payment
  • Meals for Kerendia · 2021-12-08 · $17
Sanofi PasteurVaxelis$14
1 payment
  • Meals for Vaxelis · 2021-09-30 · $14
Phadia USImmunocap$13
1 payment
  • Meals for Immunocap · 2021-12-09 · $13
Kowa Pharmaceuticals AmericaLivalo$13
1 payment
  • Meals for Livalo · 2021-07-15 · $13

Professional record

NPI
1790238046
Licence
CA 53641California G53641: Current · expires 2028-05-31
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2016-08-03
NPI last updated
2025-12-18
NPI record certified
2025-12-18

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 88 Tully Rd, San Jose, CA, 95111